XORTX Therapeutics IncXRTX
▼ NegativeCapitalrelevance
Board member departure may signal governance instability.
Impact on stocks 1
Biotech & Genomic Medicine
XORTX Therapeutics IncXORTX Therapeutics announced that Anthony Giovinazzo is stepping down from its board of directors for personal reasons and to pursue other interests. Dr. Allen Davidoff, co-CEO of XORTX, expressed appreciation for Giovinazzo's efforts as chairman of the board over the past several years, highlighting his leadership and ethical standards. XORTX is a late-stage clinical pharmaceutical company focused on developing therapies for gout and progressive kidney disease.
XORTX Therapeutics IncBoard member departure may signal governance instability.